Vaxcell-bio Therapeutics
₩3,775
0
-₩225-5.63% 06:30 Today
Statistics
Day High
4,090
Day Low
3,770
52W High
11,520
52W Low
3,350
Volume
70,416
Avg. Volume
130,328
Mkt Cap
87.48B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
May 10Expected
Q4 2020
Q1 2021
Q3 2023
Q4 2023
Q1 2024
-118
-98
-78
-58
Expected EPS
N/A
Actual EPS
N/A
Financials
-189.05%Profit Margin
Unprofitable7.06BRevenue
-13.34BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the research, development, and commercialization of immune cell-based therapies designed to treat cancer, primarily operating within South Korea. The company's main base of operations is located in Hwasun-eup, South Korea.
Show More
CEO
Jae-Jung Lee
Employees
81
Country
South Korea
ISIN
KR7323990002
Listings
0 Comments
Share your thoughts
FAQs
What is Vaxcell-bio Therapeutics stock price today?▼
The current price of 323990.KQ is ₩3,775 KRW — it has decreased by -5.63% in the past 24 hours. Watch Vaxcell-bio Therapeutics stock price performance more closely on the chart.
What is Vaxcell-bio Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Vaxcell-bio Therapeutics stocks are traded under the ticker 323990.KQ.
Is Vaxcell-bio Therapeutics stock price growing?▼
323990.KQ stock has fallen by -4.79% compared to the previous week, the month change is a -11.9% fall, over the last year Vaxcell-bio Therapeutics has showed a -59.45% decrease.
What is Vaxcell-bio Therapeutics market cap?▼
Today Vaxcell-bio Therapeutics has the market capitalization of 87.48B
What is Vaxcell-bio Therapeutics revenue for the last year?▼
Vaxcell-bio Therapeutics revenue for the last year amounts to 7.06B KRW.
What is Vaxcell-bio Therapeutics net income for the last year?▼
323990.KQ net income for the last year is -13.34B KRW.
How many employees does Vaxcell-bio Therapeutics have?▼
As of November 3, 2026, the company has 81 employees.
In which sector is Vaxcell-bio Therapeutics located?▼
Vaxcell-bio Therapeutics operates in the Health & Wellness sector.
When did Vaxcell-bio Therapeutics complete a stock split?▼
The last stock split for Vaxcell-bio Therapeutics was on November 10, 2023 with a ratio of 1.2:1.
Where is Vaxcell-bio Therapeutics headquartered?▼
Vaxcell-bio Therapeutics is headquartered in Hwasun, South Korea.